SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Board Changes

25 Sep 2025 07:00

RNS Number : 6929A
Porvair PLC
25 September 2025
 

 

For immediate release 25 September 2025

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Board Changes

Lisa Anson

Lisa Anson has been appointed as Non-Executive Director of the Company with effect from 1 October 2025.

Lisa is currently Chief Executive Officer of Redx Pharma limited, a UK based, privately held clinical-stage biotech business; a position she held when Redx was publicly listed on AIM. In addition, she is a Supervisory Board Member for Apoplex Medical Technologies GmBH, a private German company and is an elected Board Member of the UK BioIndustry Association (BIA). She was previously a Board Member and then Chair at the Association of the British Pharmaceutical Industry (ABPI).

Lisa's career spans almost 30 years in the pharmaceutical and Biotech industry including more than twenty years at AstraZeneca Plc. She has extensive global leadership and commercial experience, including several USA based roles and most recently was Country President for the UK and Ireland.

On appointment, Lisa will join the Audit Committee, Remuneration Committee and Nomination Committee of Porvair.

Porvair confirms that there are no further matters in relation to Lisa Anson's appointment to be disclosed pursuant to the requirements of paragraph 6.4.8 of the Listing Rules of the UK Listing Authority.

Sally Martin

Having completed 9 years as a Non-Executive Director at Porvair, Sally Martin will retire from the Board on 4 November 2025.

Sheena Mackay

Following Sally's retirement, Sheena Mackay will be appointed Senior Independent Director of the Board and the Non-Executive Director responsible for employee engagement, in addition to her role as Chair of the Remuneration Committee.

For further information, please contact:

Porvair plc

+44 (0)1553 765 500

Hooman Caman Javvi, Chief Executive Officer

Andrew Douglass, Group Company Secretary

 

Burson Buchanan

+44 (0)207 466 5000

Charles Ryland / Stephanie Whitmore

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEZLFLEKLZBBF
Date   Source Headline
22nd May 20269:16 amRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSAppointment of Joint Corporate Broker
24th Apr 20264:30 pmRNSHolding(s) in Company
24th Apr 202610:15 amRNSHolding(s) in Company
14th Apr 20264:29 pmRNSResults of AGM
14th Apr 20267:00 amRNSAGM Trading Update
1st Apr 20264:30 pmRNSTotal Voting Rights
26th Mar 20262:00 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSNotice of AGM
11th Mar 20267:00 amRNSNotice of AGM
3rd Mar 202610:00 amRNSHolding(s) in Company
27th Feb 20263:00 pmRNSTotal Voting Rights
24th Feb 20265:45 pmRNSDirector/PDMR Shareholding
19th Feb 20261:00 pmRNSHolding(s) in Company
17th Feb 20262:00 pmRNSDirector/PDMR Shareholding
13th Feb 20264:15 pmRNSDirector/PDMR Shareholding
9th Feb 20263:45 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSFull Year Results
6th Feb 20264:00 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
30th Jan 202612:00 pmRNSTotal Voting Rights
26th Jan 202610:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSAcquisition of Drache Umwelttechnik GmbH
6th Jan 20267:00 amRNSBlock listing Return
17th Dec 202510:00 amRNSHolding(s) in Company
15th Dec 20257:00 amRNSYear end trading update and notice of results
11th Dec 20254:00 pmRNSHolding(s) in Company
5th Dec 20259:30 amRNSHolding(s) in Company
2nd Dec 202511:00 amRNSHolding(s) in Company
27th Oct 20257:00 amRNSTotal Voting Rights
7th Oct 20257:00 amRNSBlock Listing Return
25th Sep 20257:00 amRNSBoard Changes
16th Sep 20257:00 amRNSNine Month Trading Update
4th Sep 20257:30 amRNSHolding(s) in Company
23rd Jul 20255:30 pmRNSHolding(s) in Company
23rd Jul 20259:00 amRNSHolding(s) in Company
30th Jun 20257:00 amRNSInterim Results
19th Jun 202510:04 amRNSBlocklisting Application
17th Jun 20254:40 pmRNSHolding(s) in Company
29th May 202512:00 pmRNSHolding(s) in Company
28th Apr 20259:00 amRNSHolding(s) in Company
25th Apr 20259:00 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSChange of Remuneration Committee Chair
15th Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20252:43 pmRNSAGM resolutions
15th Apr 20257:00 amRNSAGM Trading Update
9th Apr 202512:00 pmRNSBlock listing Interim Review
7th Apr 20258:00 amRNSDirector Declaration
4th Apr 202510:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.